2011 BSE, 2012 MS, 2017 PhD
Dr. Meesha Dogan is the CEO, co-founder, and director of Cardio Diagnostics, where she has led the company from breakthrough innovation to national commercialization and public listing. A pioneer at the intersection of artificial intelligence, epigenetics, and cardiovascular medicine, she co-invented the company’s core technology during her graduate studies at the University of Iowa and has led its evolution from concept to clinical impact.
Under her leadership, Cardio Diagnostics has secured strategic partnerships, multiple funding rounds, and recognition, including Fast Company’s Next Big Things in Tech and the Biotech Breakthrough Awards. Meesha holds a PhD in biomedical engineering and a BSE and an MS in chemical engineering from the University of Iowa. She was recently named to the Cardiovascular Business Forty Under 40 and Crain’s Chicago Business 40 Under 40. She is driven by both innovation and a personal mission to change the trajectory of heart disease.